Research and development cost share liability, current portion
6,182
35,700
64,345
90,596
Sale of future royalty liability, current portion
89,278
72,735
56,714
52,245
Short-term debt
190,896
116,140
57,293
813,296
Total current liabilities
2,119,187
1,811,510
1,828,830
2,368,425
Long-term debt
882,163
962,515
961,913
139,571
Sale of future royalty liability, non-current portion
817,035
831,664
850,242
832,755
Operating lease liabilities, non-current portion
48,200
49,670
52,940
51,387
Deferred tax liabilities
57,388
55,866
53,209
47,066
Research and development cost share liability, non-current portion
-
-
0
0
Other long-term liabilities
77,644
81,952
80,245
64,056
Total non-current liabilities
1,882,430
1,981,667
1,998,549
1,134,835
Total liabilities
4,001,617
3,793,177
3,827,379
3,503,260
Ordinary shares, 0.0001 par value per share 1,540,975,898 and 1,540,975,898 shares issued and 1,469,278,815 and 1,441,075,618 shares outstanding as of june 30, 2026 and december 31, 2025, respectively
147
144
144
144
Additional paid-in capital
13,054,760
12,906,326
12,759,137
12,616,844
Accumulated other comprehensive loss
-25,370
-53,482
-78,184
-101,257
Accumulated deficit
-7,855,539
-8,092,546
-8,319,903
-8,386,405
Total shareholders equity
5,173,998
4,760,442
4,361,194
4,129,326
Total liabilities and shareholders equity
9,175,615
8,553,619
8,188,573
7,632,586
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.